1. Understanding the Chameleonic Breakthrough Cancer Pain

   • Sebastiano Mercadante
   • Russell K. Portenoy

   Current Opinion 30 January 2021 Pages: 411 - 418

   

2. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis

   • Daniel Sepulveda-Crespo
   • Salvador Resino
   • Isidoro Martinez

   Leading Article 05 January 2021 Pages: 419 - 443

   

3. Detecting and Targeting NTRK Fusions in Cancer in the Era of Tumor Agnostic Oncology

   • Kristoffer S. Rohrberg
   • Ulrik Lassen

   Review Article 05 January 2021 Pages: 445 - 452

4. Novel Therapy Approaches to Follicular Lymphoma

   • Michael Northend
   • William Townsend

   Review Article 22 February 2021 Pages: 453 - 469

5. Personalized Multimorbidity Management for Patients with Type 2 Diabetes Using Reinforcement Learning of Electronic Health Records

   • Hua Zheng
   • Ilya O. Ryzhov
   • Judy Zhong

   Original Research Article 11 February 2021 Pages: 471 - 482

   

6. Secukinumab: A Review in Psoriatic Arthritis

   • Hannah A. Blair

   Adis Drug Evaluation Open access 04 March 2021 Pages: 483 - 494

7. BNT162b2 mRNA COVID-19 Vaccine: First Approval

   • Yvette N. Lamb

   AdisInsight Report 08 March 2021 Pages: 495 - 501

   

8. Orelabrutinib: First Approval

   • Sohita Dhillon

   AdisInsight Report 11 March 2021 Pages: 503 - 507

   

9. Tirbanibulin: First Approval

   • Anthony Markham
   • Sean Duggan

   AdisInsight Report 13 March 2021 Pages: 509 - 513

   

10. Correction to: Personalized Multimorbidity Management for Patients with Type 2 Diabetes Using Reinforcement Learning of Electronic Health Records

    • Hua Zheng
    • Ilya O. Ryzhov
    • Judy Zhong

    Correction 25 February 2021 Pages: 515 - 515